Lila Sciences
NativeApplied AIPrivateUpdated November 15, 2026The science superintelligence company applying AI to accelerate every dimension of scientific discovery.
- Website
- lila.ai
- Founded
- 2023
- CEO
- Geoffrey von Maltzahn
- HQ
- Cambridge, MA, United States
- Stage
- Series A
- Revenue
- Not disclosed
- Total Funding
- $550M
- Employees
- 201-500
Executive Summary
Updated Nov 1, 2026
What they do
- Builds an AI platform that generates hypotheses and designs experiments across science fields
- Runs robotic AI Science Factories that carry out experiments and feed results back to the models
- Covers life sciences, chemistry and materials science, including mRNA and CAR-T therapy research
Why it matters
- Tests AI predictions with real lab experiments, which addresses a key bottleneck in AI-driven R&D
- Well funded: $550M raised, backed by Flagship, NVentures, General Catalyst and IQT
- Reported in talks to raise about $2B at an $8.5B pre-money valuation, anchored by CalPERS and NVentures
Best fit
- Large pharma and biotech R&D groups that want to run discovery programs with a partner
- Chemicals and materials companies that want to speed up formulation and property discovery
- Organizations willing to sign a strategic co-development partnership rather than buy software off the shelf
Watch-outs
- No commercial customers or deployment terms have been publicly confirmed so far
- The model is mostly partnered discovery, not a self-serve product buyers can license
- Ownership of results and data-sharing terms in joint programs need careful negotiation
Products & Offerings
Scientific Superintelligence Platform
Lila's own AI reasoning engine that generates hypotheses, designs experiments and learns from lab results across life, chemical and materials sciences.
AI Science Factories
Automated robotic labs that run experiments around the clock, directed by Lila's AI models; a 200,000-square-foot facility in Cambridge was reported under construction in mid-2026.
Scientific Agents for R&D Partners
Custom AI science agents built for large R&D companies that need high-quality data, strong security and the ability to scale for specific programs.
RNA Discovery Engine
An autonomous discovery program that found ultra-stable mRNA designs and produced a CAR-T candidate that outperformed the leading therapy in non-human primates.
Latest News
Blockchain News · 11 days ago
PositiveUnite.AI · 2 months ago
PositiveUpdated Nov 1, 2026
Lila Sciences has unusually deep funding and a credible team from Flagship Pioneering, and it has posted early results such as autonomously discovered mRNA and CAR-T work. However, its platform is only now reaching outside partners, and no enterprise customers are named. Pharma, biotech and materials R&D leaders should open exploratory talks about partnered programs, and wait for named deployments and clear commercial terms before committing major budgets.
Signal Provenance
Latest observation date and source for each signal category
| Signal Category | Last Updated | Source |
|---|---|---|
Funding Signals Last funding round, Funding stage | Nov 14, 2026 | Cited web research |
Hiring Velocity Headcount, Headcount growth | Nov 15, 2026 | Research agents (estimate) |
Technical Output Research papers, GitHub activity | Nov 1, 2026 | Hugging Face Hub + news feed + research agents |
News Sentiment News mentions, News sentiment | Nov 15, 2026 | Verified news feed |
Partnership Signals Enterprise partnerships, Distribution partners | Nov 15, 2026 | Research agents (estimate) |
Revenue Indicators ARR estimate, Revenue growth | Nov 15, 2026 | Research agents (estimate) |
Leadership Signals CEO tenure, Founder-led | Nov 15, 2026 | Research agents (estimate) |
Competitive Position Category rank, Market share | Never | Research agents (estimate) |
Why this Bluescore?
6 dimensions, each scored 0–10 against all 250 companies. Each adds its weight × score to the Bluescore — see methodology
Lila Sciences's Bluescore of 41.4 rests most on Investment Momentum (5.0, 55th percentile) and Talent & Research (4.0, 50th percentile). Its weakest area is Data & Model Moat (3.3, 2nd percentile).
In plain English
Lila Sciences has a Bluescore of 41.4 out of 100, ranking #171 of 247, with its strongest showing in Investment Momentum, where it scores 5.0 of 10 and sits at the 55th percentile among the AI250. The biggest drag is Data & Model Moat, which scores 3.3 of 10 and places at the 2nd percentile among the AI250, so it adds only 6.3 of 19 points and leaves 12.7 unclaimed. The largest remaining opportunity is Product Depth, which carries a 21% weight, scores 3.7 of 10, and has 13.3 points still available, so improving it would move the Bluescore more than any other single dimension.
Written by AI from the scores below and checked against them; updated nightly.
Traction Signals
Last Round
Series A
Risks
Updated Nov 1, 2026